Enhanced neonatal Fc receptor function improves protection against primate SHIV infection. - Wikidata - wikimedia - TriplyDB

Enhanced neonatal Fc receptor function improves protection against primate SHIV infection.

Enhanced neonatal Fc receptor function improves protection against primate SHIV infection.

http://www.wikidata.org/entity/Q35612850

about

HIV Genome-Wide Protein Associations: a Review of 30 Years of Research Immune correlates of vaccine protection against HIV-1 acquisition TRIM21: a cytosolic Fc receptor with broad antibody isotype specificity Fc receptors and their influence on efficacy of therapeutic antibodies for treatment of viral diseases Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques Elimination of HIV-1-infected cells by broadly neutralizing antibodies Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies Patterns of HIV/SIV Prevention and Control by Passive Antibody Immunization Targeting FcRn for the modulation of antibody dynamics HIV-1 gp120 as a therapeutic target: navigating a moving labyrinth The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy Engineering antibody-like inhibitors to prevent and treat HIV-1 infection.Predicting pharmacokinetic profile of therapeutic antibodies after iv injection from only the data after sc injection in cynomolgus monkey.Broadly Neutralizing Antibodies as Treatment: Effects on Virus and Immune System Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.Neutralizing Monoclonal Antibodies to Fight HIV-1: On the Threshold of Success.Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo.Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life.Antibody engineering for increased potency, breadth and half-life.Antibodies for prevention of mother-to-child transmission of HIV-1 Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection Vectored antibody gene delivery for the prevention or treatment of HIV infection.FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin.Eliminating antibody polyreactivity through addition of N-linked glycosylation.Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-Dependent Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection.Animal models in HIV-1 protection and therapy Improving the CH1-CK heterodimerization and pharmacokinetics of 4Dm2m, a novel potent CD4-antibody fusion protein against HIV-1.Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection.A novel in vitro assay to predict neonatal Fc receptor-mediated human IgG half-life.Engineered antibody domains with significantly increased transcytosis and half-life in macaques mediated by FcRn Bispecific Antibodies Targeting Different Epitopes on the HIV-1 Envelope Exhibit Broad and Potent Neutralization.Towards HIV-1 remission: potential roles for broadly neutralizing antibodies.Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women Neutralizing antibody affords comparable protection against vaginal and rectal simian/human immunodeficiency virus challenge in macaques.The role of Fc receptors in HIV prevention and therapy.Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16 Systemic administration of an HIV-1 broadly neutralizing dimeric IgA yields mucosal secretory IgA and virus neutralization.Naturally Occurring Fc-Dependent Antibody From HIV-Seronegative Individuals Promotes HIV-Induced IFN-α Production.

P2860

Q26746070-5408701E-FF5E-45F6-ABAA-B61770C4E8B8 Q26778573-B50272E1-E6BA-40E8-9208-1EE9A16490C3 Q26779753-90D35D4B-00A0-43DE-A77F-427667100CBB Q26783175-A780A202-733B-456B-86C4-10B64ED896B0 Q27318508-B6DE373A-8A5E-4644-87FC-CFC633A152D3 Q27329126-4721BD35-C4A3-48EC-87EE-8F532A10E80F Q27644646-2197ABDF-8593-4298-B74D-C02EAA0BE69E Q28066335-1E7B47BC-E89A-4C7C-AB52-3C655D519181 Q28068018-0AFF6EC7-DA96-4A08-A7A1-538BB016CB27 Q28080589-0730FF87-9103-4110-AF73-FD6E5EC92573 Q28086826-C2C32116-B889-4479-8AB4-72D08B890295 Q28257521-269A42AC-DE49-4496-9271-E929F279B17A Q30490945-D3C0D0CD-6215-4330-8D19-3AE57EB2D62C Q31091923-3E5EA9A7-86FB-4421-AE87-18F4691DFCCD Q33592852-D153F04C-31CA-45A1-A064-EE6B7F63A289 Q33638320-28294EC3-2D62-49DA-8489-894F895FC459 Q34550046-79DB201D-9D6D-4BE7-9174-C101086FB5D3 Q34593860-0A03EC07-0CDF-400E-97E4-AAFDDB418A09 Q35569901-A3AA817C-DD7C-4331-B5AE-7080CC8B2DC4 Q35575206-8B9FC5A1-FAA4-4FA4-8301-1010C2BD5280 Q35619402-03CCB85E-0F19-4EFB-9D09-6A5A59A5B5EC Q35641234-0CD004AB-AC4D-4350-9DFF-11060CCA5AB3 Q35664155-DBD16555-2417-4F6C-BF72-4F881B529060 Q35670904-0EF74AC2-524E-4B83-BF2A-07F935D71C37 Q35684786-2B3A24CE-AC02-4A2A-AC57-6335DBD51290 Q35686912-B17BD407-6E74-4A77-AA96-A3318775B063 Q35914292-FD15B4E9-5471-4B84-9EA8-533D0711D052 Q35920037-6E78C380-16D1-486B-BB69-53C54A3241A7 Q35952586-D0D359CF-EF40-4C69-999F-96B03FFC2702 Q35974269-18817F17-6E2F-4FCF-8095-971A6AFC40FE Q36211427-E662E8DA-F042-4A8A-9A08-80D233BA684A Q36214076-B80F710E-E2A0-46E8-A8E8-8C2C24BA8DF7 Q36334359-F92899E7-6DFF-4CDE-89B6-C09BEB67009C Q36515149-EC45B41E-9610-461B-AF61-5946F0ADE5BD Q36753653-E051B64E-0010-4290-B8F9-FA8DDC1E3A7C Q37025857-495BF839-A141-4F12-BEFC-294DC702ABDB Q37113972-D368909D-9296-4E05-954C-65890352DF95 Q37245752-680F29FA-126B-406E-B2D2-07B907DB97EF Q37338339-91BDE5B7-79FF-42A7-9AEF-ED9B659BC4C6 Q37434997-06247797-FFF5-42CB-8D6E-9CF2DA68EA9B

P2860

Enhanced neonatal Fc receptor function improves protection against primate SHIV infection.

http://www.wikidata.org/entity/Q35612850

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Enhanced neonatal Fc receptor ...... gainst primate SHIV infection.

@ast

Enhanced neonatal Fc receptor ...... gainst primate SHIV infection.

@en

type

label

Enhanced neonatal Fc receptor ...... gainst primate SHIV infection.

@ast

Enhanced neonatal Fc receptor ...... gainst primate SHIV infection.

@en

prefLabel

Enhanced neonatal Fc receptor ...... gainst primate SHIV infection.

@ast

Enhanced neonatal Fc receptor ...... gainst primate SHIV infection.

@en

P1433

Q35612850-CAC9A165-9FA5-4E9A-8AC7-571CB2688AD4

P1476

Q35612850-69DA0C52-15EB-49BF-B0CD-31D2655D44A6

P2093

Q35612850-2A083CE1-F8F0-49FD-A664-A9D3D3120807

Q35612850-3BC72C80-1D60-4929-8FB2-7C94CE457667

Q35612850-43B032C0-A657-49AD-B27E-68F1D6EE3DCE

Q35612850-473DEF4E-3FC8-4D2D-8D28-A253AB8A4200

Q35612850-47C186CA-34C7-4133-91F6-F2DF978E9272

Q35612850-4F764F00-BD03-4E66-BC55-6030C8C23E80

Q35612850-5ABB883C-8733-4985-AF76-0A2AC69B3FF9

Q35612850-5BACD8E4-4949-421F-9D7E-7BD85F848A68

Q35612850-707AE4CB-6E3D-4C1D-B888-433EC0D2B1F9

Q35612850-7AE7EDA7-C8AF-4B19-BF0E-9DC6525F54A8

P2860

Q35612850-00FDA807-EAD4-45B5-B921-52B690A5A368

Q35612850-11254D9F-A82A-4A73-A6D1-B784EAD06C9A

Q35612850-175A551E-9909-475C-8D5B-C8D120A55BB9

Q35612850-1833B8AF-0F59-46EE-A486-F85F0AD5597C

Q35612850-1E4297CD-CE5F-47F5-B2D3-FDBACA97C32C

Q35612850-27E6B497-3577-4E60-852E-0A3A9125735B

Q35612850-28F31300-80F2-42D8-B902-B91BAEF46734

Q35612850-35C269D3-5280-44F2-9B49-4666BB3E6235

Q35612850-368EC31A-0D8C-4636-A839-E544DE78DC58

Q35612850-3B8D701C-672C-442B-BA4E-7B1FED83F9C8

P2888

Q35612850-2552B535-5358-4F35-BFEF-A715E66797A4

P304

Q35612850-DC313F17-D9F6-4E84-9769-C3C027EF292F

P31

Q35612850-1A28EC65-A820-4937-9141-3E4CEBDCCAED

P356

Q35612850-8A45C0D3-DF02-4BFE-BB3D-08A3FC2017A7

P407

Q35612850-5150BDBF-0879-4BC6-BF7E-398A288F7085

P433

Q35612850-7CFC5799-8B41-4F66-A2F1-D84FCCC081C9

P478

Q35612850-458320C4-4E4C-44E1-997C-E04C9B8DAD13

P50

Q35612850-0F72D877-4B76-4972-A9AC-4C93C0EFD365

Q35612850-61561B23-181C-4C48-ABFE-F46C11E78E0B

Q35612850-B5D268FF-262F-40F9-8B18-DDDDFCAC5246

P577

Q35612850-C7455161-5E78-45AD-817B-7F6B0AA178AC

P698

Q35612850-493E9100-8D8F-413B-89EF-AFC1ACE06737

P932

Q35612850-AE40B5E9-B903-42E3-8D72-FD1912FF9476

P356

P1433

P1476

Enhanced neonatal Fc receptor ...... gainst primate SHIV infection.

@en

P2093

Ashley T Haase

http://www.w3.org/2001/XMLSchema#string

John-Paul Todd

http://www.w3.org/2001/XMLSchema#string

Kevin O Saunders

http://www.w3.org/2001/XMLSchema#string

Keyun Wang

http://www.w3.org/2001/XMLSchema#string

M Gordon Joyce

http://www.w3.org/2001/XMLSchema#string

Martha C Nason

http://www.w3.org/2001/XMLSchema#string

Ming Zeng

http://www.w3.org/2001/XMLSchema#string

Rebecca S Rudicell

http://www.w3.org/2001/XMLSchema#string

Richard S Blumberg

http://www.w3.org/2001/XMLSchema#string

Saran Bao

http://www.w3.org/2001/XMLSchema#string

P2860

Functional reconstitution of human FcRn in Madin-Darby canine kidney cells requires co-expressed human beta 2-microglobulin

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

Broad neutralization coverage of HIV by multiple highly potent antibodies

Fcgamma receptors as regulators of immune responses

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

Increasing the affinity of a human IgG1 for the neonatal Fc receptor: biological consequences.

P2888

P304

642-645

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NATURE13612

http://www.w3.org/2001/XMLSchema#string

P407

P433

7524

http://www.w3.org/2001/XMLSchema#string

P478

514

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25119033

http://www.w3.org/2001/XMLSchema#string

P932

4433741

http://www.w3.org/2001/XMLSchema#string